BioPharma Resources

Drug Trial Radar · NCT01836458

A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection

An Open-label Study to Find the Minimum Inhibitory Concentration(MIC) of KAE609 in Adult Male Patients With Acute, Uncomplicated Malaria Due to Plasmodium Falciparum Monoinfection

Last checked: Nov 19, 2026Latest source record: Oct 31, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

25

Actual

Start

Jan 2014

Primary completion

Mar 2015

Study completion Mar 2015

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Apr 19, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to determine the Minimum Inhibitory Concentration of KAE609 in adult male patients with acute, uncomplicated malaria due to P.falciparum monoinfection after single dosing with KAE609

Conditions

  • Malaria

Interventions

  • KAE609Drug

    Patients will receive KAE609 single dose at a different dose level in each cohort.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Minimum Inhibitory Concentration (MIC) of KAE609Time frame: Up to Day 8 after a single dose of KAE609

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Novartis Investigative Site

    Ho Chi Minh City, Vietnam

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.